Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.

Thorpe CS, Niska JR, Girardo ME, Kosiorek HE, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE.

Breast J. 2019 Jul 23. doi: 10.1111/tbj.13423. [Epub ahead of print]

PMID:
31338974
2.

Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.

Verma V, Rwigema JM, Malyapa RS, Regine WF, Simone CB 2nd.

Radiother Oncol. 2017 Oct;125(1):21-30. doi: 10.1016/j.radonc.2017.08.005. Epub 2017 Sep 20. Review.

PMID:
28941560
3.

Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.

Badiyan SN, Rutenberg MS, Hoppe BS, Mohindra P, Larson G, Hartsell WF, Tsai H, Zeng J, Rengan R, Glass E, Katz S, Vargas C, Feigenberg SJ, Simone CB 2nd.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):280-288. doi: 10.1016/j.prro.2019.02.008. Epub 2019 Feb 23.

PMID:
30802618
4.

Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.

McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR.

Radiother Oncol. 2013 Oct;109(1):38-44. doi: 10.1016/j.radonc.2013.08.014. Epub 2013 Sep 7.

PMID:
24016675
5.

A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.

Fernandes A, Berman AT, Mick R, Both S, Lelionis K, Lukens JN, Ben-Josef E, Metz JM, Plastaras JP.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):483-7. doi: 10.1016/j.ijrobp.2015.12.005. Epub 2015 Dec 14.

PMID:
26847847
6.

Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.

Romesser PB, Cahlon O, Scher ED, Hug EB, Sine K, DeSelm C, Fox JL, Mah D, Garg MK, Han-Chih Chang J, Lee NY.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):386-95. doi: 10.1016/j.ijrobp.2016.02.036. Epub 2016 Feb 17.

7.

Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell lung carcinoma.

Kruser TJ, McCabe BP, Mehta MP, Khuntia D, Campbell TC, Geye HM, Cannon GM.

Am J Clin Oncol. 2014 Feb;37(1):70-6. doi: 10.1097/COC.0b013e31826b9950.

8.

Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy.

Margalit DN, Schoenfeld JD, Rawal B, Haddad RI, Catalano PJ, Goguen LA, Chau NG, Rabinowits G, Lorch JH, Annino DJ, Tishler RB.

Oral Oncol. 2017 Oct;73:160-165. doi: 10.1016/j.oraloncology.2017.08.012. Epub 2017 Sep 8.

PMID:
28939070
9.

Reirradiation for locoregionally recurrent non-small cell lung cancer.

Vyfhuis MAL, Rice S, Remick J, Mossahebi S, Badiyan S, Mohindra P, Simone CB 2nd.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2522-S2536. doi: 10.21037/jtd.2017.12.50. Review.

10.

Thoracic reirradiation for lung cancer: a literature review and practical guide.

Drodge CS, Ghosh S, Fairchild A.

Ann Palliat Med. 2014 Apr;3(2):75-91. doi: 10.3978/j.issn.2224-5820.2014.03.04.

11.

Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.

McAvoy S, Ciura K, Wei C, Rineer J, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):819-27. doi: 10.1016/j.ijrobp.2014.07.030. Epub 2014 Sep 11.

PMID:
25220718
12.

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.

Kline C, Liu SJ, Duriseti S, Banerjee A, Nicolaides T, Raber S, Gupta N, Haas-Kogan D, Braunstein S, Mueller S.

J Neurooncol. 2018 Dec;140(3):629-638. doi: 10.1007/s11060-018-2991-5. Epub 2018 Sep 11.

PMID:
30206764
13.

Impact of Technique and Schedule of Reirradiation Plus Hyperthermia on Outcome after Surgery for Patients with Recurrent Breast Cancer.

Oldenborg S, van Os R, Oei B, Poortmans P.

Cancers (Basel). 2019 Jun 5;11(6). pii: E782. doi: 10.3390/cancers11060782.

14.

Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences.

Margalit DN, Rawal B, Catalano PJ, Haddad RI, Goguen LA, Annino DJ, Limaye SA, Lorch JH, Lavigne AW, Schoenfeld JD, Sher DJ, Tishler RB.

Oral Oncol. 2016 Oct;61:19-26. doi: 10.1016/j.oraloncology.2016.07.012. Epub 2016 Aug 6.

PMID:
27688100
15.

Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.

Freese C, Takiar V, Fouladi M, DeWire M, Breneman J, Pater L.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):86-92. doi: 10.1016/j.prro.2016.11.005. Epub 2016 Nov 23. Review.

PMID:
28274399
16.

Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.

Makita C, Nakamura T, Takada A, Takayama K, Suzuki M, Ishikawa Y, Azami Y, Kato T, Tsukiyama I, Kikuchi Y, Hareyama M, Murakami M, Fuwa N, Hata M, Inoue T.

Radiat Oncol. 2014 Jan 14;9:26. doi: 10.1186/1748-717X-9-26.

17.

Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.

McDonald MW, Zolali-Meybodi O, Lehnert SJ, Estabrook NC, Liu Y, Cohen-Gadol AA, Moore MG.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):808-819. doi: 10.1016/j.ijrobp.2016.07.037. Epub 2016 Aug 3.

PMID:
27788954
18.

Reirradiation + hyperthermia for recurrent breast cancer en cuirasse.

Oldenborg S, Rasch CRN, van Os R, Kusumanto YH, Oei BS, Venselaar JL, Heymans MW, Zum Vörde Sive Vörding PJ, Crezee H, van Tienhoven G.

Strahlenther Onkol. 2018 Mar;194(3):206-214. doi: 10.1007/s00066-017-1241-7. Epub 2017 Dec 20.

19.

A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.

Amsbaugh MJ, Mahajan A, Thall PF, McAleer MF, Paulino AC, Grosshans D, Khatua S, Ketonen L, Fontanilla H, McGovern SL.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):144-148. doi: 10.1016/j.ijrobp.2018.12.043. Epub 2019 Jan 2.

PMID:
30610915
20.

Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.

Courdi A, Chamorey E, Ferrero JM, Hannoun-Lévi JM.

Radiother Oncol. 2013 Aug;108(2):259-65. doi: 10.1016/j.radonc.2013.06.028. Epub 2013 Jul 25.

PMID:
23891092

Supplemental Content

Support Center